Inhibitor Therapeutics (INTI) Operating Expenses (2012 - 2026)
Inhibitor Therapeutics (INTI) posted Operating Expenses of $618,597 for Q2 2026, down 11.1% from $695,773 a year earlier and down 11.1% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Operating Expenses (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Expenses at Inhibitor Therapeutics was $3.37 million, down 8.1% year-over-year; for FY2025, it was $3.43 million, down 6.3% from FY2024.
- Annual Operating Expenses shows a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
- In prior years, Inhibitor Therapeutics' Operating Expenses was $3.66 million in FY2024 (+7.4%), $3.4 million in FY2023 (+417.5%), $657,926 in FY2022 (+102.2%) and $325,395 in FY2021 (-69.3%).
- The Q2 2026 figure stands as the lowest quarterly Operating Expenses since Q2 2024.
- On a year-over-year basis, Operating Expenses increased in four of the last eight quarters, with growth averaging 0.2%.
- The strongest year-over-year quarter for Operating Expenses in the past five years was Q3 2023, with growth of 985.2%; the weakest was Q3 2021, with a decline of 78.1%.
- According to Business Quant data, Operating Expenses for the three prior quarters was $695,632 (Q1 2026), $1.32 million (Q4 2025) and $741,215 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.69 Bn | 1,103.27 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 616.29 Bn | 534.82 Bn | 17.26 Bn | 10.12 Bn |
| 3 | AbbVie | 500.86 Bn | 473.97 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 366.77 Bn | 321.15 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 235.52 Bn | 190.92 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 190.49 Bn | 164.69 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Inhibitor Therapeutics | 19.12 Mn | 11.93 Mn | - | 618,597.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 618,597.00 |
| Mar 31, 2026 | 695,632.00 |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 741,215.00 |
| Jun 30, 2025 | 695,773.00 |
| Mar 31, 2025 | 674,551.00 |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 813,196.00 |
| Jun 30, 2024 | 585,147.00 |
| Mar 31, 2024 | 774,817.00 |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 759,528.00 |
| Jun 30, 2023 | 742,461.00 |
| Mar 31, 2023 | 629,724.00 |
| Dec 31, 2022 | 423,635.00 |
| Sep 30, 2022 | 69,987.00 |
| Jun 30, 2022 | 70,804.00 |
| Mar 31, 2022 | 93,500.00 |
| Dec 31, 2021 | 28,759.00 |
| Sep 30, 2021 | 66,248.00 |
API Access
Inhibitor Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();